NF-kappaB signaling mediates vascular smooth muscle endothelin type B receptor expression in resistance arteries

European Journal of Pharmacology

Volumn 637, Issue 1-3, 2010, Pages 148-154

  Zheng, Jian Pu ^a   Zhang, Yaping ^b   Edvinsson, Lars ^a,b   Hjalt, Tord ^c   Xu, Cang Bao ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c LUND UNIVERSITY   (Sweden)

Author keywords

ETB receptor; NF B; Smooth muscle cell; Vascular disease

Indexed keywords

ENDOTHELIN B RECEPTOR; I KAPPA B; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; N (3,5 BIS TRIFLUOROMETHYLPHENYL) 5 CHLORO 2 HYDROXYBENZAMIDE; SARAFOTOXIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; WEDELOLACTONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG TARGETING; GENE EXPRESSION; GENE LOCATION; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MESENTERIC ARTERY; MUSCLE FUNCTION; MYOGRAPHY; NONHUMAN; ORGAN CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR RESISTANCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 77953290712     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.04.006     Document Type: Article

References (54)

1. Adner M., Cantera L., Ehlert F., Nilsson L., Edvinsson L. Plasticity of contractile endothelin-B receptors in human arteries after organ culture. Br. J. Pharmacol. 1996, 119:1159-1166.
2. Adner M., Geary G.G., Edvinsson L. Appearance of contractile endothelin-B receptors in rat mesenteric arterial segments following organ culture. Acta Physiol. Scand. 1998, 163:121-129.
3. Ansar S., Edvinsson L. Subtype activation and interaction of protein kinase C and mitogen-activated protein kinase controlling receptor expression in cerebral arteries and microvessels after subarachnoid hemorrhage. Stroke 2008, 39:185-190.
4. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 1997, 336:1066-1071.
5. Beg S.S., Hansen-Schwartz J.A., Vikman P.J., Xu C.B., Edvinsson L.I. Protein kinase C inhibition prevents upregulation of vascular ET(B) and 5-HT(1B) receptors and reverses cerebral blood flow reduction after subarachnoid haemorrhage in rats. J. Cereb. Blood Flow Metab. 2007, 27:21-32.
6. Cui R., Tieu B., Recinos A., Tilton R.G., Brasier A.R. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ. Res. 2006, 99:723-730.
7. De Mey J.G., Uitendaal M.P., Boonen H.C., Vrijdag M.J., Daemen M.J., Struyker-Boudier H.A. Acute and long-term effects of tissue culture on contractile reactivity in renal arteries of the rat. Circ. Res. 1989, 65:1125-1135.
8. Del Rizzo D.F., Moon M.C., Werner J.P., Zahradka P. A novel organ culture method to study intimal hyperplasia at the site of a coronary artery bypass anastomosis. Ann. Thorac. Surg. 2001, 71:1273-1279. (discussion 1279-1280).
9. Dschietzig T., Alexiou K., Richter C., Bobzin M., Baumann G., Stangl K., Brunner F. Endotoxin causes pulmonary hypertension by upregulating smooth muscle endothelin type-B receptors: role of aldose reductase. Shock 2008, 30:189-196.
10. Fletcher G.F., Bufalino V., Costa F., Goldstein L.B., Jones D., Smaha L., Smith S.C., Stone N. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke. Am. J. Cardiol. 2007, 99:1E-35E.
11. Ge C., Zhang C., Ye J., Tang X., Wu Y. Ginsenosides promote proliferation of chicken primordial germ cells via PKC-involved activation of NF-kappaB. Cell Biol. Int. 2007, 31:1251-1256.
12. Gotlieb A.I., Boden P. Porcine aortic organ culture: a model to study the cellular response to vascular injury. In Vitro 1984, 20:535-542.
13. Hamel E., Assumel-Lurdin C., Edvinsson L., Fage D., MacKenzie E.T. Neuronal versus endothelial origin of vasoactive acetylcholine in pial vessels. Brain Res. 1987, 420:391-396.
14. Hansen-Schwartz, J., Hoel, N.L., Zhou, M., Xu, C.B., Svendgaard, N.A., Edvinsson, L., 2003. Subarachnoid hemorrhage enhances endothelin receptor expression and function in rat cerebral arteries. Neurosurgery 52, 1188-1194; 1194-1185.
15. Henriksson M., Xu C.B., Edvinsson L. Importance of ERK1/2 in upregulation of endothelin type B receptors in cerebral arteries. Br. J. Pharmacol. 2004, 142:1155-1161.
16. Henriksson M., Vikman P., Stenman E., Beg S., Edvinsson L. Inhibition of PKC activity blocks the increase of ETB receptor expression in cerebral arteries. BMC Pharmacol. 2006, 6:13.
17. Hoffmann A., Natoli G., Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 2006, 25:6706-6716.
18. Iwasa S., Fan J., Shimokama T., Nagata M., Watanabe T. Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 1999, 146:93-100.
19. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18:621-663.
20. Kim J.H., Na H.K., Pak Y.K., Lee Y.S., Lee S.J., Moon A., Surh Y.J. Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells. Chem. Biol. Interact. 2008, 171:133-141.
21. Kirkby N.S., Hadoke P.W., Bagnall A.J., Webb D.J. The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house?. Br. J. Pharmacol. 2008, 153:1105-1119.
22. Kobori M., Yang Z., Gong D., Heissmeyer V., Zhu H., Jung Y.K., Gakidis M.A., Rao A., Sekine T., Ikegami F., Yuan C., Yuan J. Wedelolactone suppresses LPS-induced caspase-11 expression by directly inhibiting the IKK complex. Cell Death Differ. 2004, 11:123-130.
23. Koo E.W., Gotlieb A.I. The use of organ cultures to study vessel wall pathobiology. Scanning Microsc. 1992, 6:827-834. (discussion 835).
24. Liu H.B., Loo K.K., Palaszynski K., Ashouri J., Lubahn D.B., Voskuhl R.R. Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. J. Immunol. 2003, 171:6936-6940.
25. Loots G.G., Ovcharenko I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res. 2004, 32:W217-W221.
26. Luo G., Jamali R., Cao Y.X., Edvinsson L., Xu C.B. Vascular endothelin ET(B) receptor-mediated contraction requires phosphorylation of ERK1/2 proteins. Eur. J. Pharmacol. 2006, 538:124-131.
27. Madamanchi N.R., Vendrov A., Runge M.S. Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2005, 25:29-38.
28. Moller S., Edvinsson L., Adner M. Transcriptional regulated plasticity of vascular contractile endothelin ET(B) receptors after organ culture. Eur. J. Pharmacol. 1997, 329:69-77.
29. Morotti A., Parvis G., Cilloni D., Familiari U., Pautasso M., Bosa M., Messa F., Arruga F., Defilippi I., Catalano R., Rosso V., Carturan S., Bracco E., Guerrasio A., Saglio G. CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536. Leukemia 2007, 21:1305-1306.
30. N'Guessan P.D., Temmesfeld-Wollbruck B., Zahlten J., Eitel J., Zabel S., Schmeck B., Opitz B., Hippenstiel S., Suttorp N., Slevogt H. Moraxella catarrhalis induces ERK- and NF-kappaB-dependent COX-2 and prostaglandin E2 in lung epithelium. Eur. Respir. J. 2007, 30:443-451.
31. Neumann M., Naumann M. Beyond IkappaBs: alternative regulation of NF-kappaB activity. FASEB J. 2007, 21:2642-2654.
32. Nilsson D., Wackenfors A., Gustafsson L., Edvinsson L., Paulsson P., Ingemansson R., Malmsjo M. Increased ET(A) and ET(B) receptor contraction in the left internal mammary artery from patients with hypertension. J. Hum. Hypertens. 2008, 22:226-229.
33. Nilsson D., Wackenfors A., Gustafsson L., Ugander M., Ingemansson R., Edvinsson L., Malmsjo M. PKC and MAPK signalling pathways regulate vascular endothelin receptor expression. Eur. J. Pharmacol. 2008, 580:190-200.
34. Ohkita M., Takaoka M., Shiota Y., Nojiri R., Matsumura Y. Nitric oxide inhibits endothelin-1 production through the suppression of nuclear factor kappa B. Clin. Sci. (Lond.) 2002, 103(Suppl 48):68S-71S.
35. Ohsuzu F. The roles of cytokines, inflammation and immunity in vascular diseases. J. Atheroscler. Thromb. 2004, 11:313-321.
36. Rey S., Corthorn J., Chacon C., Iturriaga R. Expression and immunolocalization of endothelin peptides and its receptors, ETA and ETB, in the carotid body exposed to chronic intermittent hypoxia. J. Histochem. Cytochem. 2007, 55:167-174.
37. Schmitz M.L., Bacher S., Kracht M. I kappa B-independent control of NF-kappa B activity by modulatory phosphorylations. Trends Biochem. Sci. 2001, 26:186-190.
38. Schneider M.P., Boesen E.I., Pollock D.M. Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. Annu. Rev. Pharmacol. Toxicol. 2007, 47:731-759.
39. Stenman E., Malmsjo M., Uddman E., Gido G., Wieloch T., Edvinsson L. Cerebral ischemia upregulates vascular endothelin ET(B) receptors in rat. Stroke 2002, 33:2311-2316.
40. Tanaka A., Konno M., Muto S., Kambe N., Morii E., Nakahata T., Itai A., Matsuda H. A novel NF-kappaB inhibitor, IMD-0354, suppresses neoplastic proliferation of human mast cells with constitutively activated c-kit receptors. Blood 2005, 105:2324-2331.
41. Uddman E., Moller S., Adner M., Edvinsson L. Cytokines induce increased endothelin ET(B) receptor-mediated contraction. Eur. J. Pharmacol. 1999, 376:223-232.
42. Uddman E., Adner M., Edvinsson L. Protein kinase C inhibitors decrease endothelin ET(B) receptor mRNA expression and contraction during organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2002, 452:215-222.
43. Uddman E., Henriksson M., Eskesen K., Edvinsson L. Role of mitogen-activated protein kinases in endothelin ETB receptor up-regulation after organ culture of rat mesenteric artery. Eur. J. Pharmacol. 2003, 482:39-47.
44. Vikman P., Edvinsson L. Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur. J. Neurol. 2006, 13:1324-1332.
45. Vikman P., Ansar S., Henriksson M., Stenman E., Edvinsson L. Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Exp. Brain Res. 2007, 183:499-510.
46. Wackenfors A., Emilson M., Ingemansson R., Hortobagyi T., Szok D., Tajti J., Vecsei L., Edvinsson L., Malmsjo M. Ischemic heart disease induces upregulation of endothelin receptor mRNA in human coronary arteries. Eur. J. Pharmacol. 2004, 484:103-109.
47. Wang X., Tong M., Chinta S., Raj J.U., Gao Y. Hypoxia-induced reactive oxygen species downregulate ETB receptor-mediated contraction of rat pulmonary arteries. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L570-L578.
48. Wilson S.H., Simari R.D., Lerman A. The effect of endothelin-1 on nuclear factor kappa B in macrophages. Biochem. Biophys. Res. Commun. 2001, 286:968-972.
49. Wort S.J., Ito M., Chou P.C., Mc Master S.K., Badiger R., Jazrawi E., de Souza P., Evans T.W., Mitchell J.A., Pinhu L., Ito K., Adcock I.M. Synergistic induction of endothelin-1 by tumor necrosis factor alpha and interferon gamma is due to enhanced NF-{kappa}B binding and histone acetylation at specific {kappa}B sites. J. Biol. Chem. 2009, 284:24297-24305.
50. Xu C.B., Stenman E., Edvinsson L. Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin. Biochem. Pharmacol. 2002, 64:497-505.
51. Xu C.B., Zheng J.P., Zhang W., Zhang Y., Edvinsson L. Lipid-soluble smoke particles upregulate vascular smooth muscle ETB receptors via activation of mitogen-activating protein kinases and NF-kappaB pathways. Toxicol. Sci. 2008, 106:546-555.
52. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
53. Zhang Y., Adner M., Cardell L.O. Interleukin-1beta attenuates endothelin B receptor-mediated airway contractions in a murine in vitro model of asthma: roles of endothelin converting enzyme and mitogen-activated protein kinase pathways. Clin. Exp. Allergy 2004, 34:1480-1487.
54. Zhang W., Zhang Y., Edvinsson L., Xu C.B. Up-regulation of thromboxane A(2) receptor expression by lipid soluble smoking particles through post-transcriptional mechanisms. Atherosclerosis 2008, 196:608-616.